RE: MrIndia6 Jun 2022 11:17
MrIndia, there has been a lack of market appreciation but not a lack of news, as pharma goes Hemo has been steaming ahead. As for future news, Vlad did not give the impression he was about to slow down at the investor meetings. He is flat out on multiple pipelines and I am confident we will see updates and progress towards clinical trials.
All that said, your worrying again ONLY because 1 or 2 people sold this morning in big far below spread. They didnt spread it out and get a better price, they dumped 1m and took what they could get. Its just a guess, but based on the HUGE amount of ramping over the weekend on telegram for CLON it was related some how, maybe margin call or something. The same names I saw ramping away are the same names who have ramped HEMO in the past. There was a poll yesterday afternoon, 10 stocks, what stock people thought would do well this week, 24% of people had voted for CLON and people in there only ever vote for what stocks they are holding.
I understand your frustration, but NOTHING happens in isolation, there was no update or change here to make Hemo a better or worse investment today over last week. For me the weekend was fantastic, much needed detachment from the stock market, I look this morning and I see 2 sells, whoopie :P 2...... I see an opportunity to take advantage of someone elses misery but I dont have the funds to action.
I see dusters in oil stocks YET again, the stocks that everyone loves to trade and pump yet again dont fail to deliver and wipe people out, the biggest pump of last week decimating people and it just reaffirms my decision to stick with Hemo.
We are not a binary play, we are not waiting for results, we are not going to see placings and we are not sitting on ATH's.
Hemo is an under the radar small mCap pharma with the financial reserves to get to clinical trials with multiple pipelines and ongoing talks with multiple big pharmas who have just finished talking with FDA and are well on their way to preparing an IND.
The SP remains, as it has been, $41T.
The Website remains antiquated and in need of an update
But good god, the prospects here are HUGE and its so nice not to be sitting on a O&G P&D pile of crock. This will deliver.